USPTO Grants Patent for Tableted Cannabinoid Chewing Gum
Summary
The USPTO has granted a patent (US12582602B2) to NordicCan A/S for a tableted chewing gum composition containing cannabinoids. The patent describes a layered chewing gum with water-insoluble and water-soluble components designed for oral administration of cannabinoids.
What changed
The United States Patent and Trademark Office (USPTO) has granted patent US12582602B2 to NordicCan A/S for a novel tableted cannabinoid chewing gum. The patent abstract details a composition comprising a plurality of particles, including a gum base and water-soluble chewing gum ingredients, structured in at least two layers. The composition is designed for oral administration and includes one or more cannabinoids.
This patent grant is primarily an intellectual property event and does not impose new regulatory obligations on pharmaceutical companies or drug manufacturers. However, it signifies a new development in the formulation and delivery of cannabinoid-based products, which may be relevant for companies operating in the pharmaceutical and cannabis sectors. Compliance officers should note this development as it pertains to potential future product innovation and market exclusivity in this evolving area.
Source document (simplified)
Tableted cannabinoid chewing gum with tableted modules
Grant US12582602B2 Kind: B2 Mar 24, 2026
Assignee
NordicCan A/S
Inventors
Heidi Ziegler Bruun, Dorthe Schackinger Boesen, Ane Eriksen
Abstract
A tableted chewing gum composition for oral administration of cannabinoids includes a plurality of particles, including a first population of particles having water-insoluble gum base and a second population of particles having water-soluble chewing gum ingredients. The composition constitutes at least two layers, where a first layer of the composition has water-insoluble gum base and a second layer of the composition, which is cohered to and adjacent to the first layer, has water-soluble chewing gum ingredients. The second layer is free of water-insoluble gum base, and the composition includes one or more cannabinoids.
CPC Classifications
A61K 47/02 A61K 9/19 A61K 31/515 A61K 9/01
Filing Date
2023-10-24
Application No.
18493276
Claims
22
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: Patent Grants - Pharma (A61K) publishes new changes.